Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of life science market reports and research services

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India

Be the first to review this product

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India

Summary

GlobalData, the industry analysis specialist, has released its latest report, 'CountryFocus: Healthcare, Regulatory...
You can choose to pay by purchase order during checkout

Availability: In stock

$1,995.00

* Required Fields

You can choose to pay by purchase order during checkout
GlobalData.

Digital downloads direct to your inbox within 24 hours.

First class customer service from our team of experts.

Pay by credit card or request an invoice

Product Description

Details

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India

Summary

GlobalData, the industry analysis specialist, has released its latest report, 'CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India'. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in India. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

India is the second most populated country in the world with a population of approximately 1.24 billion in 2014. The country's pharmaceutical market was estimated at $24.2 billion in 2014 and is expected to reach approximately $60.5 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 16.5%. The value of the Indian medical device market was $6.6 billion in 2008, and is expected to register a CAGR of 7.7% to reach an estimated $10.3 billion in 2020.

The main growth factors are -
- Increasing coverage of healthcare insurance
- Improving access to medical facilities in both urban and rural areas
- Government initiatives for easy access to healthcare facilities

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in India, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Dr Reddy's, Lupin, Cipla, Aurobindo and Cadila; and profiles and SWOT analyses of the major players in the medical device market: Siemens Healthcare, Johnson & Johnson, DePuy, Roche and Philips
- Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving India's healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect India's healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
- Identify, understand, and capitalize on the opportunities and challenges in India's healthcare market

Additional Information

Additional Information

Publisher name GlobalData.
Format PDF
Page count 235
Publication date 11 Jan 2016
Table of contents 1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 9
1.2 List of Figures 13
2 Introduction 17
2.1 GlobalData Report Guidance 17
3 Overview of the Pharmaceutical and Medical Device Markets 18
3.1 Pharmaceutical Market 18
3.1.1 Market Overview 18
3.1.2 Pharmaceutical Exports and Imports 22
3.1.3 Supply Channels 23
3.1.4 Market Segments 24
3.1.5 Major Therapeutic Areas 26
3.1.6 Major Players 30
3.2 Medical Device Market 57
3.2.1 Market Overview 57
3.2.2 Overview of Top Five Segments 60
3.2.3 Diagnostic market 70
3.2.4 Major Players 72
3.3 Market Drivers and Barriers 101
3.3.1 Drivers 101
3.3.2 Barriers 102
4 Market Access 106
4.1 Reimbursement and Payer Landscape 106
4.1.1 Overview of Healthcare System 106
4.1.2 Reimbursement Process 109
4.1.3 Overview of Insurance Providers 114
4.1.4 Patient Share in Healthcare Spending 118
4.1.5 Drug Price Change 119
4.1.6 Pricing Policies 121
4.2 Regulatory Landscape 123
4.2.1 Overview of Regulatory Agencies 123
4.2.2 New Drug Approval Procedure for Pharmaceutical Products 125
4.2.3 Market Authorization Procedure for Medical Devices 128
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 130
4.2.5 Licensing Process for Pharmaceutical Exports and Imports 131
4.2.6 Intellectual Property Rights 132
4.2.7 Clinical Trial Regulations 138
4.2.8 Pharmaceutical Advertising Regulations 140
4.2.9 Pharmacy Regulations 141
4.2.10 Labeling and Packaging Regulations 142
5 Country Analysis 144
5.1 Political Environment 144
5.1.1 Political Structure 144
5.1.2 Analysis of the Current Political Environment 145
5.1.3 Healthcare Policy Initiatives 146
5.2 Economic Landscape 148
5.3 Economic Indicators 149
5.3.1 Gross Domestic Product 149
5.3.2 National Income per Capita 154
5.3.3 Inflation 155
5.3.4 Currency Exchange Rate 158
5.3.5 Foreign Direct Investment 159
5.3.6 Foreign Exchange Reserves 161
5.3.7 Trade Balance 162
5.3.8 Government Structural Balance 164
5.3.9 General Government Gross Debt 166
5.3.10 Major Industries 168
5.4 Demographics 169
5.4.1 Population 169
5.4.2 Education and Literacy 187
5.4.3 Employment 189
5.4.4 Disease Burden 192
5.5 Healthcare Infrastructure 194
5.5.1 Healthcare Facilities 194
5.5.2 Healthcare Parameters 201
5.5.3 Environmental Health 203
5.5.4 Healthcare Personnel 206
5.6 Healthcare Expenditure 209
5.6.1 Overview 209
5.6.2 Components of Healthcare Spending 210
5.6.3 Public and Private Sector Share 212
5.6.4 Spending in Pharmaceutical R&D 213
5.7 Trade Associations 214
5.7.1 Indian Pharmaceutical Association 214
5.7.2 Indian Drug Manufacturer's Association 214
5.7.3 Organization of Pharmaceutical Producers of India 214
5.7.4 Indian Pharmacy Graduates Association 215
5.8 Trade Fairs 215
6 Opportunities and Challenges 216
6.1 Opportunities 216
6.2 Challenges 217
7 Appendix 219
7.1 Abbreviations 219
7.2 Bibliography 223
7.3 Research Methodology 232
7.3.1 Coverage 232
7.3.2 Secondary Research 233
7.3.3 Forecasts 234
7.3.4 Expert Panel 234
7.4 Disclaimer 234

Reviews

Write Your Own Review

Only registered users can write reviews. Please, log in or register

Product Tags

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.